# 111, Inc.: overview YI · Nasdaq · CIK 1738906 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/yi.md) · [Financials](/companies/yi/financials.md) · [Filings](/companies/yi/filings.md) · [Insiders](/companies/yi/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,950](/filings/0001104659-22-052772.md) | [1,960](/filings/0001104659-23-051944.md) | [2,105](/filings/0001104659-24-060922.md) | [1,973](/filings/0001410578-25-001911.md) | [1,795](/filings/0001104659-26-052002.md) | | Gross margin | % | [31.9%](/filings/0001104659-24-060922.md) | [42.9%](/filings/0001410578-25-001911.md) | [40.3%](/filings/0001104659-26-052002.md) | [42.0%](/filings/0001104659-26-052002.md) | [40.3%](/filings/0001104659-26-052002.md) | | Operating margin | % | [(5.2%)](/filings/0001104659-22-052772.md) | [(2.7%)](/filings/0001104659-23-051944.md) | [(2.3%)](/filings/0001104659-24-060922.md) | [0.0%](/filings/0001410578-25-001911.md) | [(0.0%)](/filings/0001104659-26-052002.md) | | Net margin | % | [(5.0%)](/filings/0001104659-22-052772.md) | [(2.8%)](/filings/0001104659-23-051944.md) | [(2.4%)](/filings/0001104659-24-060922.md) | [(0.1%)](/filings/0001410578-25-001911.md) | [(0.2%)](/filings/0001104659-26-052002.md) | | Diluted EPS | $ per share | [(0.63)](/filings/0001104659-22-052772.md) | [(0.36)](/filings/0001104659-23-051944.md) | [(0.33)](/filings/0001104659-24-060922.md) | [(0.05)](/filings/0001410578-25-001911.md) | [(0.05)](/filings/0001104659-26-052002.md) | | Free cash flow | $m | [(118)](/filings/0001104659-22-052772.md) | [(7.9)](/filings/0001104659-23-051944.md) | [(64.4)](/filings/0001104659-24-060922.md) | [34.0](/filings/0001410578-25-001911.md) | [16.4](/filings/0001104659-26-052002.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/yi/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Serenus Wealth Advisors, LLC](/funds/2053695.md) | 2026-06-30 | $358.7k | 4,320 | | Unchanged | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $75.3k | 17,339 | | New +17,339 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $56.0k | 12,914 | | Reduced −100 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $6.9k | 1,597 | | Added +1,497 | | [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $647 | 149 | | Added +5 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $490 | 113 | | Unchanged | | [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $194 | 47 | | Reduced −5 | | [RHUMBLINE ADVISERS](/funds/1115418.md) | 2026-06-30 | $95 | 22 | | Unchanged | ## Recent filings [All 132 filings](/companies/yi/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-28 | 06:33 ET | [6-K](/filings/0000950103-26-014553.md) | Report of a foreign private issuer, period 2026-09-28 | 0000950103-26-014553 | | 2026-09-17 | 06:16 ET | [SCHEDULE 13D](/filings/0001104659-26-108394.md) | Ownership report, active investor | 0001104659-26-108394 | | 2026-09-17 | 06:12 ET | [6-K](/filings/0000950103-26-014069.md) | Report of a foreign private issuer, period 2026-09-17 | 0000950103-26-014069 | | 2026-09-17 | 06:08 ET | [6-K](/filings/0000950103-26-014068.md) | Report of a foreign private issuer, period 2026-09-17 | 0000950103-26-014068 | | 2026-06-04 | 06:54 ET | [6-K](/filings/0000950103-26-008498.md) | Report of a foreign private issuer, period 2026-06-04 | 0000950103-26-008498 | | 2026-04-30 | 06:04 ET | [20-F](/filings/0001104659-26-052002.md) | Annual report of a foreign private issuer, period 2025-12-31 | 0001104659-26-052002 | | 2026-04-09 | 06:08 ET | [6-K](/filings/0000950103-26-005529.md) | Report of a foreign private issuer, period 2026-04-09 | 0000950103-26-005529 | | 2025-12-17 | 06:13 ET | [6-K](/filings/0000950103-25-016208.md) | Report of a foreign private issuer, period 2025-12-17 | 0000950103-25-016208 | | 2025-09-17 | 06:09 ET | [6-K](/filings/0000950103-25-011737.md) | Report of a foreign private issuer, period 2025-09-17 | 0000950103-25-011737 | | 2025-06-20 | 06:20 ET | [6-K](/filings/0000950103-25-007647.md) | Report of a foreign private issuer, period 2025-06-20 | 0000950103-25-007647 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-052002.md), filed Apr 30, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1738906 - Tickers: YI - Exchange: Nasdaq - SIC code: 5912 Retail-Drug Stores and Proprietary Stores - State of incorporation: E9 - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 06:07 ET. No prices; not investment advice.